Luzon Credit: Why The Product-Responsibility Overhang Is Still On The Balance Sheet
The Tria platform shrank sharply, but the stock of loans already purchased under product responsibility still rose to ILS 26.9 million before allowance, while the net balance-sheet asset increased to ILS 7.8 million. The new flow pressure eased, but the legacy credit tail is still there.
The main article argued that 2025 was the year Tria's platform shrank hard, and that 2026 would be judged on capital, underwriting and the build-out of a new engine. This continuation isolates what was left behind after that shrinkage: the stock of troubled loans already purchased under product responsibility, which is still sitting on the balance sheet even as the managed book falls quickly.
That matters because the income statement looks calmer than the balance sheet. The managed credit book on the platform fell from ILS 2.331 billion to ILS 1.240 billion, a drop of about 47%. Yet the amount of loans actually purchased under product responsibility rose from ILS 25.8 million to ILS 26.9 million, and the allowance for impairment rose from ILS 17.3 million to ILS 18.3 million.
That is the core gap. The flow weakened, but the old stock did not come down with it. The balance-sheet asset under product responsibility also increased from ILS 7.093 million to ILS 7.769 million, while the matching liability in payables and accruals rose from ILS 0.8 million to ILS 1.04 million. So even if the pace of new damage is moderating, the legacy tail is still on the company and still requires collections work, management attention and capital absorption.
What Is Actually Sitting On The Balance Sheet
The product-responsibility mechanism is meant to protect lenders from excessive exposure to a single loan. Once a platform loan is more than 60 days delinquent, and a lender's exposure to that loan is above the diversification level the company committed to, the company buys the excess piece. The threshold is 0.5% of an investor's portfolio in the standard product, or 0.2% in the expanded-responsibility version.
From that point, the issue is no longer just weaker origination economics. The troubled loan moves onto the company's balance sheet, with an aggressive age-based impairment policy: 30% after 60 days, 70% after 150 days, 90% after 270 days and 100% after 730 days. In addition, a lender asking to withdraw their entire balance can transfer loans that have been more than 60 days delinquent under a broadly similar impairment model. That is why the legacy stock does not disappear automatically when the active platform shrinks and withdrawal queues are cleared.
That chart captures the story well. Maximum exposure fell from about ILS 484.4 million to ILS 389.2 million, but the amount already realized, meaning loans the company had actually purchased, went up. The realized share of maximum exposure therefore rose from 5.3% to 6.9%. That is not the pattern of a legacy tail washing out with the platform. It is the pattern of an old credit stock remaining stuck, and becoming heavier relative to what is left of the platform.
The Flow Improved, The Stock Did Not
| Metric | 2024 | 2025 | Change | Why it matters |
|---|---|---|---|---|
| Managed credit book on the platform | ILS 2,331.3 million | ILS 1,239.8 million | -46.8% | The old operating engine contracted very quickly |
| Maximum product-responsibility exposure | ILS 484.4 million | ILS 389.2 million | -19.6% | Potential exposure fell, but it did not disappear |
| Loans actually purchased | ILS 25.8 million | ILS 26.9 million | +4.5% | The troubled legacy stock did not fall, it increased |
| Allowance for impairment | ILS 17.3 million | ILS 18.3 million | +5.9% | The company is still carrying the depth of the issue |
| Balance-sheet asset tied to product responsibility | ILS 7.093 million | ILS 7.769 million | +9.5% | The legacy overhang is still sitting in assets |
| Matching liability in payables and accruals | ILS 0.800 million | ILS 1.040 million | +30.0% | The opposite side of the mechanism did not disappear either |
| Annual product-responsibility expense in cost of services | ILS 2.230 million | ILS 0.226 million | -89.9% | The current flow eased, but this is not a clean balance-sheet resolution |
The easy-to-misread datapoint is the sharp drop in annual product-responsibility expense, from ILS 2.23 million to just ILS 226 thousand. That does say that 2025 produced less fresh damage than 2024. But it does not say the company has already cleaned up the stock accumulated in prior periods. On the contrary, the stock already purchased, the allowance booked against it and the balance-sheet asset that remains all stayed material at year-end.
Put differently, there are two different questions here. One is whether fresh damage is still being created at the same pace. On that question, there is improvement. The second is what happens to the old damage that has already moved onto the balance sheet. On that question, the picture is still not clean.
Why The Lower Expense Does Not Close The Case
The report shows revenue falling from ILS 52.884 million to ILS 31.703 million, while operating profit of ILS 12.183 million turned into an operating loss of ILS 1.832 million. Operating cash flow moved from positive ILS 17.302 million to negative ILS 4.454 million, and cash and cash equivalents fell from about ILS 41.2 million to ILS 36.1 million. After the balance-sheet date, the company raised net proceeds of ILS 102.7 million, but that capital raise mainly addresses financial flexibility and the ability to build new growth. It does not erase loans already purchased, and it does not by itself shorten the collection cycle on those loans.
That is why the balance sheet matters more than the annual expense line. In the income statement, product responsibility looks like a problem that largely quieted down in 2025. In the balance sheet, it still looks like a stock of old credit the company is holding, impairing and collecting over time.
Timing matters as well. From the start of 2025 through the report date, withdrawal requests exceeded deposit requests by about ILS 330 million. The company also states that by January 25, 2026 it had met all withdrawal requests opened through December 31, 2025, in an aggregate amount of about ILS 2 billion plus roughly ILS 220 million of accumulated interest. That reduces the immediate operational pressure from the withdrawal queue, but it does not change the fact that troubled loans already purchased remain on the balance sheet until they are collected.
So 2026 can look better on liquidity and on the rebuilding of activity, while still looking less clean on old credit quality. Anyone trying to decide whether the company is really moving through this chapter should look for a real decline in balances, not only for the disappearance of a current-period expense.
What Has To Happen Next
- First test: the amount of loans actually purchased has to start coming down, not merely stop rising quickly.
- Second test: the impairment allowance needs to fall alongside the gross balance. If the allowance stays high, actual collections are still slow or weak.
- Third test: the balance-sheet asset and the matching liability need to contract through collections and repayments back to investors, not simply become less visible because of new equity or a new growth engine.
- Fourth test: new activity, especially the Nawi et Luzon venture, should be judged separately from the legacy stock. If the new engine grows while product-responsibility legacy is not cleaning up, the company is simply carrying both stories at once.
Conclusion
The key point is that 2025 improved the pace of fresh damage, but it did not close out the old stock. The managed platform book was almost cut in half, yet the loans actually purchased under product responsibility still rose, the impairment allowance increased and the balance-sheet asset remained material.
That is why reading the sharp drop in annual expense as a near-complete cleanup misses the more important line item. The line that matters is the balance sheet. Until there is a clear decline in the purchased-loan balance, the accumulated allowance and the balance-sheet asset, product responsibility remains an old credit tail sitting on Luzon Credit even as the company tries to build a new chapter.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.